Diagnostic test based on urinary tumor markers hold promise for earlier or prompt detection of bladder cancer in patients ...
Overall survival appears no worse for patients with organ-confined limited-stage small cell bladder cancer receiving multimodal organ-preserving treatment. For patients with limited-stage small-cell ...
Hosted on MSN
Does TARA stock’s 15% after-hours slump signal a bargain after new bladder cancer data?
・The company reported strong efficacy and a clean safety profile from its ongoing Phase 2 Advanced-2 bladder cancer trial. ・Durability signals were notable, with 68% of BCG-unresponsive patients and ...
We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. Relmada Therapeutics, Inc. is one of them. Relmada Therapeutics, Inc. (NASDAQ:RLMD) is a clinical-stage biotechnology ...
Please provide your email address to receive an email when new articles are posted on . Patients with advanced muscle-invasive bladder cancer had lower risk for local recurrence with adjuvant ...
Results of two phase 3 studies — IMvigor011 and DYNAMIC-III — presented at the European Society for Medical Oncology (ESMO) Annual Meeting 2025 suggest that circulating tumor DNA (ctDNA) could help ...
How Do Cancer Survivors Fare After Lung Cancer Screening? Among patients undergoing first-time lung cancer screening, cancer survivors may have a slightly higher cancer detection rate. Medscape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results